Approach to NSCLC With Targetable Mutations (EGFR, ALK and ROS-1)

Approach to NSCLC With Targetable Mutations (EGFR, ALK and ROS-1)

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Jorge J Nieva, M.D.

Date of Release

May 14th, 2025